These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 17627092

  • 1. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
    Peterkova V, Arslanoglu I, Bolshova-Zubkovskaya E, Romer T, Zdravkovic D, Kratzsch J, Ji HJ, Savoy C, Saenger P.
    Horm Res; 2007; 68(6):288-93. PubMed ID: 17627092
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 3. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T, Saenger P, Peter F, Walczak M, Le Bouc Y, Khan-Boluki J, Berghout A.
    Horm Res; 2009 Aug; 72(6):359-69. PubMed ID: 19844125
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 5. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
    Stamoyannou L, Karachaliou F, Neou P, Papataxiarchou K, Pistevos G, Bartsocas CS.
    Am J Med Genet; 1997 Oct 03; 72(1):71-6. PubMed ID: 9295079
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
    Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M.
    J Pediatr Gastroenterol Nutr; 2007 Oct 03; 45(4):433-7. PubMed ID: 18030209
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of a new ready-to-use recombinant human growth hormone solution.
    Romer T, Peter F, Saenger P, Starzyk J, Koehler B, Korman E, Walczak M, Wasik R, Ginalska-Malinowska M, Solyom E, Berghout A.
    J Endocrinol Invest; 2007 Oct 03; 30(7):578-89. PubMed ID: 17848841
    [Abstract] [Full Text] [Related]

  • 8. Long-term safety and efficacy of the recombinant human growth hormone Omnitrope® in the treatment of Spanish growth hormone deficient children: results of a phase III study.
    López-Siguero J, Borrás Pérez MV, Balser S, Khan-Boluki J.
    Adv Ther; 2011 Oct 03; 28(10):879-93. PubMed ID: 21948492
    [Abstract] [Full Text] [Related]

  • 9. Weight relative to height before and during growth hormone therapy in prepubertal children.
    Kaplowitz PB, Rundle AC, Blethen SL.
    Horm Metab Res; 1998 Sep 03; 30(9):565-9. PubMed ID: 9808325
    [Abstract] [Full Text] [Related]

  • 10. 24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.
    Khadilkar V, Radjuk KA, Bolshova E, Khadgawat R, El Kholy M, Desai M, Peterkova V, Mericq V, Kratzsch J, Siepl EC, Martin D, Lopez P, Ji HJ, Bae YJ, Lee JH, Saenger PH.
    J Clin Endocrinol Metab; 2014 Jan 03; 99(1):126-32. PubMed ID: 24170106
    [Abstract] [Full Text] [Related]

  • 11. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
    Rachmiel M, Rota V, Atenafu E, Daneman D, Hamilton J.
    Horm Res; 2007 Jan 03; 68(5):236-43. PubMed ID: 17396034
    [Abstract] [Full Text] [Related]

  • 12. TNF-alpha levels in children with growth hormone deficiency and the effect of long-term growth hormone replacement therapy.
    Andiran N, Yordam N.
    Growth Horm IGF Res; 2007 Apr 03; 17(2):149-53. PubMed ID: 17314057
    [Abstract] [Full Text] [Related]

  • 13. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
    Bajpai A, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2006 Jul 03; 43(7):593-9. PubMed ID: 16891678
    [Abstract] [Full Text] [Related]

  • 14. A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.
    Moore WV, Nguyen HJ, Kletter GB, Miller BS, Rogers D, Ng D, Moore JA, Humphriss E, Cleland JL, Bright GM.
    J Clin Endocrinol Metab; 2016 Mar 03; 101(3):1091-7. PubMed ID: 26672637
    [Abstract] [Full Text] [Related]

  • 15. Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).
    Péter F, Bidlingmaier M, Savoy C, Ji HJ, Saenger PH.
    J Clin Endocrinol Metab; 2012 Feb 03; 97(2):400-7. PubMed ID: 22162481
    [Abstract] [Full Text] [Related]

  • 16. Linear growth response to recombinant human growth hormone in children with growth hormone deficiency.
    Shih KC, Ho LT, Kuo HF, Chang TC, Liu PC, Chen CK, Tiu CM.
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jul 03; 54(1):7-13. PubMed ID: 8087727
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV, Dana K, Frane J, Lippe B.
    Pediatr Endocrinol Rev; 2008 Sep 03; 6(1):5-8. PubMed ID: 18806719
    [Abstract] [Full Text] [Related]

  • 18. Use of growth hormone in children.
    Hindmarsh PC, Dattani MT.
    Nat Clin Pract Endocrinol Metab; 2006 May 03; 2(5):260-8. PubMed ID: 16932297
    [Abstract] [Full Text] [Related]

  • 19. Final height in Swedish children with idiopathic growth hormone deficiency enrolled in KIGS treated optimally with growth hormone.
    Westphal O, Lindberg A, Swedish KIGS National Board.
    Acta Paediatr; 2008 Dec 03; 97(12):1698-706. PubMed ID: 18976357
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone therapy and children with idiopathic short stature: a viable option?
    Willhaus J.
    Pediatr Nurs; 1999 Dec 03; 25(6):662-5. PubMed ID: 12024388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.